Invion Ltd has released a press release.
Agreement with Major South Korean Pharma Group Hanlim
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Invion
- INV043 With ICI Therapy Achieved 80% Tumour Control For ASCC
- Agreement with Dr.inB to develop Photosoft treatment for HPV
- AGM Presentation
- Major Milestone towards Clinical Trials
- Investor Presentation
Later from Invion
- Invion secures funding through an institutional placement
- Ph 2 Prostate Cancer Results Strong Safety and 40% Response
- Invion Limited (ASX: IVX) Prostate Cancer Trial Results
- Consolidation/Split - IVX
- Invion Doses First Patient in Phase I/II Skin Cancer Trial
Follow Invion into a list and get an email when it puts out news.
Follow Invion